Requirement for CD154 in the progression of atherosclerosis
暂无分享,去创建一个
M. Daemen | R. Flavell | L. Gorelik | V. Koteliansky | E. Lutgens | I. Grewal | E. Muinck
[1] P. Groot,et al. Chemokines and atherosclerosis. , 1999, Atherosclerosis.
[2] K. Williams,et al. Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.
[3] H. Wellens,et al. Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques. , 1999, Cardiovascular research.
[4] P. Doevendans,et al. Atherosclerosis in APOE*3-Leiden transgenic mice: from proliferative to atheromatous stage. , 1999, Circulation.
[5] R. Terkeltaub,et al. Chemokines and atherosclerosis. , 1998, Current opinion in lipidology.
[6] P. Libby,et al. Reduction of atherosclerosis in mice by inhibition of CD40 signalling , 1998, Nature.
[7] D. Richman,et al. CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[8] P. Libby,et al. CD40 signaling in vascular cells: a key role in atherosclerosis? , 1998, Atherosclerosis.
[9] P. Libby,et al. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? , 1997, Circulation research.
[10] P. Libby,et al. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. , 1997, Circulation.
[11] A. Tall,et al. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. , 1997, The Journal of clinical investigation.
[12] J. D. Smith,et al. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[13] P. Libby,et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[14] T. Mayadas,et al. Absence of P-selectin delays fatty streak formation in mice. , 1997, The Journal of clinical investigation.
[15] R. Flavell,et al. A central role of CD40 ligand in the regulation of CD4+ T-cell responses. , 1996, Immunology today.
[16] R. Flavell,et al. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand , 1995, Nature.
[17] A. Matsushima,et al. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals , 1995, The Journal of experimental medicine.
[18] W D Wagner,et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[19] W D Wagner,et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Circulation.
[20] R. Ross,et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[21] J. Bajorath,et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome , 1993, Cell.
[22] E. Döpp,et al. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in rat recognized by monoclonal antibodies ED1, ED2 and ED3. , 1985, Advances in experimental medicine and biology.